Treatment-emergent adverse events and antiseizure medication actual drug load.

Fiche du document

Type de document
Périmètre
Langue
Identifiants
Relations

Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.yebeh.2022.108980

Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/36375306

Ce document est lié à :
info:eu-repo/semantics/altIdentifier/eissn/1525-5069

Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_7D05EB7BE2F85

Licences

info:eu-repo/semantics/openAccess , CC BY-NC-ND 4.0 , https://creativecommons.org/licenses/by-nc-nd/4.0/



Sujets proches En

Therapy

Citer ce document

T. Prétat et al., « Treatment-emergent adverse events and antiseizure medication actual drug load. », Serveur académique Lausannois, ID : 10.1016/j.yebeh.2022.108980


Métriques


Partage / Export

Résumé 0

The correlation between treatment-emergent adverse events (TEAE) and antiseizure medication (ASM) drug load is a controversial topic. Previous studies used daily defined dosage (DDD) to measure drug load. We aim to assess if ASM adjusted to body weight and plasma levels were associated with TEAE. We analyzed clinical visits of a trial on therapeutic drug monitoring in outpatients with epilepsy. TEAE, treatment, and its changes, as well as ASM plasma levels, were recorded at each visit. Each medication level was stratified according to its position in relation to its proposed reference range (below, in the lower half, upper half, or above). We analyzed 424 visits (151 participants). Treatment-emergent adverse events were reported in 84 (20%) visits. There was no significant difference when comparing visits with TEAE with those without TEAE in terms of ASM drug load (calculated with DDD), corrected for body weight, their changes since the last visit, as well as summed plasma levels compared to reference ranges. Actual drug load seems not to represent a major determinant of TEAE recorded during routine visits, even when accounting thoroughly for the patient's exposure to the treatment. The use of structured questionnaires and neuropsychometric tests may assess more accurately the potential consequences of drug loads.

document thumbnail

Par les mêmes auteurs

Sur les mêmes sujets

Exporter en